These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26287355)

  • 1. [Therapeutic effects of human umbilical cord mesenchymal stem cell transplantation on acute graft versus host disease].
    Zheng Y; Wang Y; Zhai Z; Zhai Q; Hu SY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):869-72. PubMed ID: 26287355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mesenchymal stem cells as salvage therapy for steroid resistant acute graft-versus-host disease following haploidentical hematopoietic stem cell transplantation].
    Xue M; Wang ZD; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):878-80. PubMed ID: 22339970
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.
    Wu KH; Chan CK; Tsai C; Chang YH; Sieber M; Chiu TH; Ho M; Peng CT; Wu HP; Huang JL
    Transplantation; 2011 Jun; 91(12):1412-6. PubMed ID: 21494176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
    Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages.
    Ringden O; Le Blanc K
    Best Pract Res Clin Haematol; 2011 Mar; 24(1):65-72. PubMed ID: 21396594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.
    Bernardo ME; Ball LM; Cometa AM; Roelofs H; Zecca M; Avanzini MA; Bertaina A; Vinti L; Lankester A; Maccario R; Ringden O; Le Blanc K; Egeler RM; Fibbe WE; Locatelli F
    Bone Marrow Transplant; 2011 Feb; 46(2):200-7. PubMed ID: 20400983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease.
    Tisato V; Naresh K; Girdlestone J; Navarrete C; Dazzi F
    Leukemia; 2007 Sep; 21(9):1992-9. PubMed ID: 17625609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
    Introna M; Lucchini G; Dander E; Galimberti S; Rovelli A; Balduzzi A; Longoni D; Pavan F; Masciocchi F; Algarotti A; Micò C; Grassi A; Deola S; Cavattoni I; Gaipa G; Belotti D; Perseghin P; Parma M; Pogliani E; Golay J; Pedrini O; Capelli C; Cortelazzo S; D'Amico G; Biondi A; Rambaldi A; Biagi E
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):375-81. PubMed ID: 24321746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
    Si Y; Yang K; Qin M; Zhang C; Du Z; Zhang X; Liu Y; Yue Y; Feng Z
    Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
    Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
    Lancet; 2004 May; 363(9419):1439-41. PubMed ID: 15121408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches in GVHD therapy.
    Svennilson J
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S65-7. PubMed ID: 15812534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response.
    Calkoen FG; Jol-van der Zijde CM; Mearin ML; Schweizer JJ; Jansen-Hoogendijk AM; Roelofs H; van Halteren AG; Egeler RM; van Tol MJ; Ball LM
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1590-9. PubMed ID: 23994245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyserositis as a manifestation of graft-versus-host disease.
    Khalil A; Ben Barak A; Zaidman I; Elhasid R; Rowe JM; Ben-Arush M
    Pediatr Hematol Oncol; 2011 Nov; 28(8):691-3. PubMed ID: 22023464
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.
    Prasad VK; Lucas KG; Kleiner GI; Talano JA; Jacobsohn D; Broadwater G; Monroy R; Kurtzberg J
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):534-41. PubMed ID: 20457269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.
    Tucunduva L; Volt F; Cunha R; Locatelli F; Zecca M; Yesilipek A; Caniglia M; Güngör T; Aksoylar S; Fagioli F; Bertrand Y; Addari MC; de la Fuente J; Winiarski J; Biondi A; Sengeloev H; Badell I; Mellgren K; de Heredia CD; Sedlacek P; Vora A; Rocha V; Ruggeri A; Gluckman E;
    Br J Haematol; 2015 Apr; 169(1):103-10. PubMed ID: 25521756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation.
    Lee SH; Lee MW; Yoo KH; Kim DS; Son MH; Sung KW; Cheuh H; Choi SJ; Oh W; Yang YS; Koo HH
    Bone Marrow Transplant; 2013 Aug; 48(8):1040-5. PubMed ID: 23396407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease.
    Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ
    Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease.
    Park M; Lee SH; Lee YH; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Ahn HS; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Han DK; Baek HJ; Kook H; Hwang TJ; Lee EK; Hah JO; Lim YJ; Jung HJ; Park JE; Jang MJ; Chong SY; Oh D;
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):640-6. PubMed ID: 23380345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
    Le Blanc K; Frassoni F; Ball L; Locatelli F; Roelofs H; Lewis I; Lanino E; Sundberg B; Bernardo ME; Remberger M; Dini G; Egeler RM; Bacigalupo A; Fibbe W; Ringdén O;
    Lancet; 2008 May; 371(9624):1579-86. PubMed ID: 18468541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.